Dr. LLM Will See You Now: The Ability of ChatGPT to Provide Geographically Tailored Colorectal Cancer Screening and Surveillance Recommendations.

Background/

Objectives

This study evaluates the performance of a large language model (lLm) in providing geographically tailored colorectal cancer screening and surveillance recommendations to gastrointestinal surgeons.

Methods

Fifty-four patient cases, varying by age and family history, were developed based on colorectal cancer guidelines. Standardized prompts with predefined query terms were used to query ChatGPT-4.5 on 18 April 2025, from four locations: Canada, Italy, Romania, and the United Kingdom. Responses were classified as "Correct," "Partially Correct," or "Incorrect" based on clinical guidelines and expert recommendations for each country. Outcomes were analyzed using descriptive statistics.

Results

ChatGPT provided recommendations on screening eligibility, test interpretation, the management of positive results, and surveillance intervals. Correct recommendations were given for 50.0% (27/54) of cases in Canada, 63.0% (34/54) of cases in Italy, 40.7% (22/54) of cases in Romania, and 55.6% (30/54) of cases in the United Kingdom. Queries in Italian yielded correct guidance for 64.8% (35/54) of cases, while Romanian queries were accurate for 40.7% (22/54) of cases. Notably, Romania and Italy lacked detailed guidelines for polyp management and post-test surveillance. A key finding was the inconsistency between ChatGPT-generated titles and corresponding recommendations, which may impact its reliability in clinical decision-making.

Conclusions

ChatGPT-4.5's performance varies by country and language, highlighting inconsistencies in geographically tailored recommendations. This study highlights limitations associated with the training data cutoff and the potential biases introduced by model-generated responses. Healthcare professionals should recognize these limitations and the possible gaps in guideline availability, particularly for high-risk screening, polyp management, and surveillance in certain European countries.